Revvityvs.Waters Corporation
RVTY vs WAT · both in Life science tools, part of the Medicine, pharma & life science value chain: Instruments, reagents and equipment for research, development and production.
Waters Corporation is about 3.0× larger than Revvity by market cap; Revvity trades at the lower P/E (52.6 vs 83.5); year to date, Revvity leads (+16.1% vs −0.9%).
Side by side
| RVTY | WAT | |
|---|---|---|
| Market cap | $12.6B | $37.5B |
| Price | $112.29 | $376.43 |
| Today | −0.6% | −0.2% |
| Return YTD | +16.1% | −0.9% |
| Return 1Y | +9.7% | +6.6% |
| P/E | 52.6 | 83.5 |
| P/S | 4.3 | 9.9 |
| P/B | 1.8 | 2.5 |
Data as of 2026-07-11 · updates daily after U.S. close
The two companies
RevvityRVTY
Life science tools and diagnostics across newborn screening and research.
Full RVTY profile →Waters CorporationWAT
Analytical instruments (chromatography and mass spectrometry) for pharma and labs.
Full WAT profile →More comparisons in Life science tools
See where RVTY and WAT sit in the full Medicine, pharma & life science map — every segment from suppliers to end markets.Open the Life science value chain →